Arrowgrass Capital Partners (US)’s Zimmer Biomet ZBH Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-265,890	Closed	-$28.2M	–	539
2015 Q2	$28.2M	Sell	265,890 -82,813	-24%	-$9.16M	0.42%	47
2015 Q1	$39.8M	Buy	348,703 +120,453	+53%	+$13.7M	0.61%	23
2014 Q4	$25.1M	Buy	228,250 +156,150	+217%	+$16.5M	0.45%	34
2014 Q3	$7.04M	Buy	+72,100	New	+$7.09M	0.17%	90
2014 Q1	–	Sell	-30,900	Closed	-$2.8M	–	200
2013 Q4	$2.8M	Buy	+30,900	New	+$2.67M	0.13%	111

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ZBH Position: Q3 2015 in Review

Arrowgrass Capital Partners (US) sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 265,890 shares — an estimated $28.2M sold.

Arrowgrass Capital Partners (US) first reported a position in ZBH in Q4 2013 and held it in 5 quarters. The position peaked at $39.8M in Q1 2015. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Arrowgrass Capital Partners (US) reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 265,890 Zimmer Biomet shares in Q3 2015, an estimated $28.2M.
Arrowgrass Capital Partners (US) first reported a position in Zimmer Biomet in Q4 2013 and held it in 5 quarters.
Arrowgrass Capital Partners (US)'s Zimmer Biomet position peaked at $39.8M in Q1 2015.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2015, filed 16 Nov 2015.